Skip to main content
. 2020 Oct 17;99(3):115244. doi: 10.1016/j.diagmicrobio.2020.115244

Table 3A.

Comparison of nosocomial and community-acquired PIV-3.

Hospital-acquired Community-acquired P value
n = 104 (24.3%) n = 324 (75.7%)
Study population
 Age [years] [median (IQR)] 58 (29.25-64.75) 3 (1-61) <0.0005
 Female gender [%(n/total)] 41.3 (43/104) 42.6 (138/324) 0.823
Comorbidities/risk factors
 History of malignant neoplasia [%(n/total)] 75.0 (78/104) 19.8 (64/324) <0.0005
 Blood malignancy [%(n/total)] 69.2 (72/104) 14.2 (46/324) <0.0005
 Solid cancer [%(n/total)] 14.4 (15/104) 7.4 (24/324) 0.031
 Immunosuppression [%(n/total)] 73.1 (76/104) 20.1 (65/324) <0.0005
 Chronic renal failure [%(n/total)] 22.1 (23/104) 15.4 (50/324) 0.115
 Cardiac insufficiency [%(n/total)] 11.5 (12/104) 14.2 (46/324) 0.491
 Asthma [%(n/total)] 2.9 (3/104) 6.8 (22/324) 0.140
 COPD [%(n/total)] 3.8 (4/104) 14.5 (47/324) 0.004
 Obesity (BMI >30 kg/m²) [%(n/total)] 19.4 (13/67) 6.2 (14/227) 0.001
Clinical presentation and features
 Leucocytes on admission [exp 9/l] [median (IQR)] 6.8 (4.2-9.3) 10.3 (6.9-14.3) <0.0005
 Length of hospitalization [days] [median (IQR)] 36.5 (22-68.75) 7 (4-12.75) <0.0005
 Admission to ICU [%(n/total)] 27.9 (29/104) 21.9 (71/324) 0.211
 Length of stay in ICU [days] [median (IQR)] 28 (5-70) 5 (3-12.5) 0.001
 Acute respiratory distress syndrome [%(n/total)] 1.0 (1/104) 1.9 (6/324) 0.533
 Ventilation [%(n/total)] 18.4 (19/103) 10.2 (33/324) 0.026
   Invasive [%(n/total)] 15.5 (16/103) 8.3 (27/324) 0.034
   Noninvasive [%(n/total)] 2.9 (3/103) 1.9 /6/324) 0.514
 Viral co-infection [%(n/total)] 23.1 (24/104) 31.2 (101/324) 0.114
 Death (<30 days after discharge) [%(n/total)] 8.7 (9/104) 4.6 (15/324) 0.121

COPD = chronic obstructive pulmonary disease; PIV-3 = parainfluenza virus type 3. Analyzed categories are displayed on the column to the left and either given as frequencies [%] or median and interquartile range [median(IQR)]. (n/total) indicates the respective cases of the total amount of available data. A comparison was done for the whole study period and a P value <0.05 was considered significant (highlighted in bold).